toripalimab
coherus biosciences,shanghai junshi bioscience
['toripalimab', 'urothelial']
preliminary results of a phase ib/ii combination study of rc48-adc, a novel humanized anti-her2 adc with toripalimab, a humanized igg4 mab against pd-1 in pts with locally adv or metastatic #urothelialcarcinoma. presented by xinan sheng md, abft &gt; #asco22 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology